Un document
Highlights
Highlights
❰❱
Actualités
Protecting livelihoods in the era of climate change: KfW and Green Climate Fund launch first cooperative programme in Bangladesh
Frankfurt am Main (ots) - - Adapting urban infrastructure to the impacts of climate change - Reducing the risk of flooding KfW and the Green Climate Fund (GCF) have signed their first financing agreement, thereby marking the start of their joint promotion of climate change adaptation measures in Bangladesh. With a ...
plusNew Study Demonstrates Significant Clinical Workflow and Staff Experience Benefits of Philips' Azurion Image-guided Therapy Platform
Amsterdam (ots/PRNewswire) - - Two year study* found that clinicians' use of Azurion enabled significant reductions in procedure time, in-lab patient preparation time, post-procedure lab time and enhanced staff experience - Improvements correspond to the ability to treat one additional patient per interventional lab ...
plusEMA grants Orphan Drug Designation to Debiopharm International SA's FGFR inhibitor Debio 1347 in the treatment of biliary tract cancer
Lausanne (ots) - Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, today announced that the European Medicines Agency (EMA) granted Orphan Drug Designation to Debio 1347 for treatment of Biliary Tract Cancer affecting around ...
plusEANS-News: Rosenbauer International AG / Consolidated revenues and order backlog stable
issuer: Rosenbauer International AG Paschingerstrasse 90 A-4060 Leonding phone: +43(0)732 6794 568 FAX: +43(0)732 6794 89 mail: ir@rosenbauer.com WWW: www.rosenbauer.com ISIN: AT0000922554 indexes: WBI stockmarkets: Stuttgart, Wien, Berlin language: English ...
plusAscensia Diabetes Care Celebrates Inspirational Women On World Diabetes Day 2017
Basel, Switzerland (ots/PRNewswire) - Today, Ascensia Diabetes Care, a leading diabetes care company, is showing its support for World Diabetes Day 2017 by publishing 30 portraits of inspiring women who are making significant contributions to advancing diabetes care. The theme of World Diabetes Day is Women and Diabetes, and through this initiative, Ascensia aims to ...
plusMerck Receives FDA Approval for New GONAL-f® Prefilled Pen
Darmstadt, Germany (ots/PRNewswire) - - New pen is easy-to-learn and easy-to-use, supporting the one in six couples affected by infertility in the U.S.[1] - Insights of patients, nurses and doctors helped to evolve the product Merck, a leading science and technology company, today announced that the company received approval for a new version of GONAL-f® (follitropin alfa injection) prefilled pen from the U.S. Food and ...
plus
Ronald Plasterk Joins myTomorrows as Chief Scientific Officer
Amsterdam (ots/PRNewswire) - myTomorrows announces that Ronald Plasterk, a renowned molecular geneticist and until recently Dutch Minister of the Interior and Kingdom Relations, joins the company as Chief Scientific Officer, effective 1 December 2017. Plasterk will primarily focus on creating academic partnerships to address specific areas of unmet medical need, supporting myTomorrows' aim to facilitate early access to ...
plusKfW-Research: Germans see the need for a 'mobility transition' - majority in favour of a speed limit on autobahns
Frankfurt am Main (ots) - - Representative survey: respondents agree change is necessary - High willingness to change personal behaviour also confirmed - One in three respondents has already changed their mobility behaviour - Scepticism towards e-mobility still widespread In the face of increasingly congested roads, ...
plusCinemo presented at Renesas' 1st European R-Car Consortium Forum in Düsseldorf, Germany
Karlsruhe (ots) - Creative automotive multimedia set to reach new heights in performance and originality as Cinemo middleware deliver unprecedented content control to Renesas R-Car Systems-on-Chip Cinemo, a global leader in high performance and automotive grade multimedia playback, streaming, media management, connectivity and cloud access middleware, today announced ...
plus/OFF HOLD OFF HOLD OFF HOLD -- European Centre for Medium-Range Weather Forecasts/
Reading, England (ots/PRNewswire) - /OFF HOLD OFF HOLD OFF HOLD -- European Centre for Medium-Range Weather Forecasts, PIV890504 The following release: "New Seasonal Prediction System SEAS5 Brings Better El Niño Forecasts" is now OFF HOLD. Distribution time: 10 Nov 2017 00:01 GMT The European Centre for Medium-Range Weather Forecasts (ECMWF) today launches its latest ...
plusJTI Japan Tobacco International AG
ILO Postpones Decision on Partnerships to Eliminate Child Labor in Tobacco
Geneva (ots/PRNewswire) - JTI Calls for Continued Coordinated Approach in the Interest of Tobacco Growing Communities JTI (Japan Tobacco International) commends the Governing Body of the International Labour Organization (ILO) for postponing its decision on the continuation of the ILO's partnerships with the tobacco sector in the fight against child labor. ARISE ...
plusRising Digital Expectations of Customers and Citizens Drive Investments in Technology, Finds 2017 CGI Client Global Insights
Montréal (ots/PRNewswire) - 40% of executives have an enterprise-wide digital strategy in place, up from 12% in 2016 CGI (TSX: GIB.A) (NYSE: GIB) released its 2017 CGI Client Global Insights, which demonstrate an increased urgency among business and IT leaders to transform to meet the digital expectations of their ...
plus
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
Darmstadt, Germany (ots/PRNewswire) - - First multiple sclerosis (MS) therapy to achieve positive NICE recommendation in the shortest possible timeframe - Mavenclad has shown sustained clinical efficacy up to four years with a maximum of 20 days of oral treatment over two years Merck, a leading science and technology company, today announced that the National Institute ...
plusEANS-News: Rosenbauer International AG / Schiphol Group relies on Rosenbauer / New PANTHER for Amsterdam, Rotterdam and Lelystad airports - IMAGE
http://resources.euroadhoc.com/images/11/5/10073235/_56A5599_A.jpg issuer: Rosenbauer International AG Paschingerstrasse 90 A-4060 Leonding phone: +43(0)732 6794 568 FAX: +43(0)732 6794 89 mail: ir@rosenbauer.com WWW: www.rosenbauer.com ISIN: AT0000922554 indexes: WBI stockmarkets: Wien, Berlin, Stuttgart ...
plusNeurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field
Zurich (ots/PRNewswire) - Neurimmune, a global leader in the discovery and development of human-derived monoclonal antibodies, today announced that it has entered into a collaboration with Ono Pharmaceutical Co., Ltd. focused on the development of human antibodies against a novel therapeutic target for neurodegenerative diseases. Under the terms of the collaboration ...
plusOxThera Strengthens Patent Portfolio for Treatment of Hyperoxaluria
Stockholm (ots/PRNewswire) - OxThera AB announced today that it has recently been granted two new US patents, three new European patents and patents in Canada, China, Hong-Kong, India and Japan. OxThera now holds proprietary rights to pharmaceutical preparations and their use for treatment of hyperoxaluria in nine patent families. The newly granted US patents have ...
plusEQS-Adhoc: Leclanché SA: EPAL Partners with Leclanché and Deltro and Invests US $12 million in First Utility-scale Canadian Energy Storage Project
EQS Group-Ad-hoc: Leclanché SA / Key word(s): Investment/Financing Leclanché SA: EPAL Partners with Leclanché and Deltro and Invests US $12 million in First Utility-scale Canadian Energy Storage Project 08-Nov-2017 / 18:27 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely ...
plusRichmont Mines Reports Strong Third Quarter Financial Results Driven by Record Gold Production and Solid Cost Performance at Island Gold
Toronto (ots/PRNewswire) - Richmont Mines Inc. (TSX: RIC) (NYSE: RIC) ("Richmont" or the "Corporation") announces operating and financial results for the three and nine months ended September 30, 2017. (All amounts are in Canadian dollars, unless otherwise indicated.) THIRD QUARTER AND NINE-MONTH HIGHLIGHTS - ...
plus
EANS-News: voestalpine AG / voestalpine reports best half year?s results since ?Lehman?
issuer: voestalpine AG voestalpine-Straße 1 A-4020 Linz phone: +43 50304/15-9949 FAX: +43 50304/55-5581 mail: IR@voestalpine.com WWW: www.voestalpine.com ISIN: AT0000937503 indexes: WBI, ATX stockmarkets: Wien language: English ...
plusSTELARA® (ustekinumab) Shows Positive Results in Treatment of Systemic Lupus Erythematosus in Phase 2 Trial
Beerse, Belgium (ots/PRNewswire) - FOR MEDICAL AND TRADE MEDIA ONLY - 60% of patients receiving ustekinumab showed significant reductions in lupus disease activity vs. 31% of patients receiving placebo - Ustekinumab showed significant improvements in various disease measures compared with placebo, including ...
plusNew Phase 2 Data Show Treatment With TREMFYA® (guselkumab) Improved Psoriatic Arthritis Symptoms Through One Year
Beerse, Belgium (ots/PRNewswire) - FOR MEDICAL AND TRADE MEDIA ONLY Longer-term results demonstrate continued efficacy of anti-interleukin 23 monoclonal antibody guselkumab in improving joint and skin symptoms associated with active psoriatic arthritis Janssen Research & Development, LLC (Janssen) announced today ...
plusEANS-Adhoc: ams AG / ams and Sunny Opotech, part of Sunny Optical Technology Group, enter collaboration to develop and market 3D sensing camera solutions for mobile device and automotive applications
issuer: ams AG Tobelbader Strasse 30 A-8141 Premstaetten phone: +43 3136 500-0 FAX: +43 3136 500-931211 mail: investor@ams.com WWW: www.ams.com ISIN: AT0000A18XM4 indexes: stockmarkets: SIX Swiss Exchange language: English ...
plusNew Phase 2 Data Show Treatment With TREMFYA® (guselkumab) Improved Psoriatic Arthritis Symptoms Through One Year
Beerse, Belgium (ots/PRNewswire) - FOR MEDICAL AND TRADE MEDIA ONLY Longer-term results demonstrate continued efficacy of anti-interleukin 23 monoclonal antibody guselkumab in improving joint and skin symptoms associated with active psoriatic arthritis Janssen Research & Development, LLC (Janssen) announced today ...
plusSTELARA® (ustekinumab) Shows Positive Results in Treatment of Systemic Lupus Erythematosus in Phase 2 Trial
Beerse, Belgium (ots/PRNewswire) - FOR MEDICAL AND TRADE MEDIA ONLY - 60% of patients receiving ustekinumab showed significant reductions in lupus disease activity vs. 31% of patients receiving placebo - Ustekinumab showed significant improvements in various disease measures compared with placebo, including ...
plus
Global Experts Call for Action on Vaccination Apathy, and More Protection for Older Adults Against Infectious Diseases
Berlin (ots/PRNewswire) - - 'Vaccination apathy' is a key barrier to protecting the community against infectious disease, according to global health experts - By 2060, 30% of Europeans will be aged 65 years or over[1] - a life-course approach to immunisation, including adult vaccination, is a cost-effective method ...
plusAT & S Austria Technologie und Systemtechnik Aktiengesellschaft
EANS-Adhoc: AT & S Austria Technologie und Systemtechnik Aktiengesellschaft / AT&S decides to issue a subordinated bond (hybrid bond)
issuer: AT & S Austria Technologie und Systemtechnik Aktiengesellschaft Fabriksgasse 13 A-8700 Leoben phone: 03842 200-0 FAX: mail: e.koch@ats.net WWW: www.ats.net ISIN: AT0000969985 indexes: ATX GP, VÖNIX, WBI stockmarkets: Wien language: English ...
plusNew GSK Multi-country Survey Reveals Need for Improved Awareness Around Long-term Impact and Appropriate use of Corticosteroids in SLE Management
San Diego and London (ots/PRNewswire) - Findings from a new multi-country GSK survey, released today to coincide with the 2017 American College of Rheumatology/Association for Rheumatology Health Professionals Annual Meeting (ACR/AHRP), reveal that patients with systemic lupus erythematosus (SLE) often self-manage ...
plusLeading Independent Proxy Advisory Firms Recommend Alamos and Richmont Shareholders Vote in Favour of Proposed Plan of Arrangement
Toronto (ots/PRNewswire) - Alamos Gold Inc. ("Alamos") (TSX: AGI) (NYSE: AGI) and Richmont Mines Inc. ("Richmont") (TSX: RIC) (NYSE: RIC) today announced that Institutional Shareholder Services Inc. ("ISS") and Glass, Lewis & Co., LLC ("Glass Lewis"), two leading proxy advisory firms, have recommended that both ...
plusSwitching to Tresiba® is Highly Cost-effective and Cost-saving in a Real-world Setting
Glasgow, Scotland (ots/PRNewswire) - Poster Presentation PDB27 A new analysis of real-world data has shown that switching to Tresiba® (insulin degludec) is highly cost-effective and cost-saving for the treatment of type 1 and type 2 diabetes, respectively.[1] The analysis was presented today at the International Society for Pharmacoeconomics and Outcomes Research ...
plusDebiopharm International SA Announces Dosing of First Patient in a Combination Trial of Debio 1143 and Avelumab in Patients with Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC)
Lausanne, Switzerland (ots) - The clinical trial is in collaboration with the Merck-Pfizer Alliance Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, today announced the dosing of the first patient in a Phase Ib study of Debio ...
plus
Précédent180181182183184185186187188189Suivant